The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review
SARS-CoV-2/Coronavirus 2019 (COVID-19) is responsible for the pandemic, which started in December 2019. In addition to the typical respiratory symptoms, this virus also causes other severe complications, including neurological ones. In diagnostics, serological and polymerase chain reaction tests are...
Main Authors: | Joanna Kulikowska, Agnieszka Kulczyńska-Przybik, Barbara Mroczko, Alina Kułakowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/11/5894 |
Similar Items
-
Non-Surgical Resolution of Cerebrospinal Fluid Fistula Caused by Nasal Swab for COVID-19 Diagnosis. A Case Report
by: De Sousa-Fontes, Aderito, et al.
Published: (2024-04-01) -
Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19
by: Maria Antonella Zingaropoli, et al.
Published: (2023-09-01) -
Neuro-Behçet: report of three clinically distinct cases
by: Giorgio Fabiani, et al.
Published: (2001-06-01) -
Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies
by: Joanna Kulikowska, et al.
Published: (2024-02-01) -
Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting
by: Tamara van Gorkom, et al.
Published: (2022-06-01)